Evidence map›Paper›PMID 9665997›Full record

ArticleJournal of clinical microbiology1998

Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.

R B Domingues, F D Lakeman, M S Mayo, R J Whitley

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Herpes Simplex Encephalitis: an Update.Current infectious disease reports · 2017
    Review
  10. HSV Encephalitis with Normal CSF - A Case Report with Review of Literature.Journal of clinical and diagnostic research : JCDR · 2015
    Article
  11. Fifteen minute consultation: managing neonatal and childhood herpes encephalitis.Archives of disease in childhood. Education and practice edition · 2015
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neonatal herpes simplex virus infections: where are we now?Advances in experimental medicine and biology · 2011
    Review
  18. Article
  19. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis.Journal of perinatology : official journal of the California Perinatal Association · 2009
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R B DominguesDepartment of Pathology, University of São Paulo, Brazil.
F D Lakeman
M S Mayo
R J Whitley

Funding

EFFICACY TRIALS OF ANTIVIRALS FOR SEVERE HERPES VIRUSN01AI012667 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD J · 1985 to 1986
–
THERAPIES FOR SEVERE HERPES VIRUS INFECTIONN01AI015113 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITIEY, RICHARD D · 1991 to 1995
–
TRIAL ON ANTIVIRALS FOR SEVERE HERPESVIRUS INFECTIONSN01AI062554 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD J · 1986 to 1990
–
NIAID NIH HHS N01-AI-12667NIAID NIH HHS N01-AI-15113NIAID NIH HHS N01-AI-62554
6 · The paper itself

Abstract

The purpose of the present study was to determine if the quantity of herpes simplex virus (HSV) DNA in the cerebrospinal fluid (CSF) of patients with herpes encephalitis would be useful in establishing the prognosis of the disease and to determine the effect of antiviral therapy on the clearance of viral DNA from the CSF. Quantitation of HSV DNA was done by constructing an internal standard (IS) from the glycoprotein B amplicon which had a 25-bp deletion between primer annealing sites. Each CSF specimen was coamplified with the IS and the ratio of the amount of HSV/amount of IS was compared to the ratios on a standard curve constructed with the same IS plus known amounts of HSV DNA. CSF specimens were available from 16 patients who were treated with intravenous acyclovir, and the amount of HSV DNA ranged from < 25 to 18,000 copies per microliter in CSF obtained before or within 4 days of the initiation of acyclovir therapy. Patients with > 100 copies of HSV DNA per microliter were older, were found by computed tomography to have lesions, and had poorer outcomes than patients with < 100 copies. Follow-up CSF specimens were available from seven patients. In six of these seven patients, the HSV DNA levels decreased during therapy. One patient had a twofold increase in HSV DNA levels after 1 week of therapy and died on day 8. The application of this assay may be helpful in establishing the prognosis and in the monitoring of patients with herpes simplex encephalitis.

Indexed as

AcyclovirAdolescentAdultAntiviral AgentsBase SequenceCerebrospinal FluidChildChild, PreschoolDNA, ViralEncephalitis, ViralFemaleHerpes SimplexHerpesvirus 1, HumanHumansInfantMaleAcyclovirAntiviral AgentsDNA, Viralglycoprotein B, SimplexvirusViral Envelope Proteins

Identifiers

PMID9665997
PMCPMC105021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.